(Q38908254)

English

Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

Zulfiqar Bhutta

1

object named as

Zulfiqar A Bhutta

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Alessandra Anemona

7

object named as

Alessandra Anemona

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

18

object named as

Audino Podda

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Elisa Marchetti

4

object named as

Elisa Marchetti

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Rana M Qasim Khan

11

object named as

Rana M Qasim Khan

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

author name string

Maria Rosario Capeding

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Ashish Bavdekar

3

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Shabina Ariff

5

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Sajid B Soofi

6

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Muhammad A Habib

8

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Edison Alberto

9

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Sanjay Juvekar

10

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Rachid Marhaba

12

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Noshad Ali

13

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Nelia Malubay

14

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Anand Kawade

15

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Allan Saul

16

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Laura B Martin

17

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

publication date

28 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Lancet Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

119-129

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970241-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970241-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A study of typhoid fever in five Asian countries: disease burden and implications for controls

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970241-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Typhoid fever in children aged less than 5 years

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970241-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Bacteremic typhoid fever in children in an urban slum, Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970241-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Typhoid fever in children: some epidemiological considerations from Karachi, Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970241-X

7 January 2021

based on heuristic

inferred from DOI database lookup

New advances in typhoid Fever vaccination strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970241-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970241-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970241-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Typhoid fever in Bangladesh: implications for vaccination policy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970241-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970241-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Production of a conjugate vaccine for Salmonella enterica serovar Typhi from Citrobacter Vi.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970241-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of Citrobacter sp. line 328 as a source of Vi for a Vi-CRM(197) glycoconjugate vaccine against Salmonella Typhi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970241-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety, immunogenicity and dose ranging of a new Vi-CRM₁₉₇ conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970241-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Burden of typhoid and paratyphoid fever in a densely populated urban community, Dhaka, Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970241-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970241-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(13)70241-X

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38908254&oldid=2042145728"